Preprint / Version 1

COVID-19 Pneumonia and Tocilizumab use: Case Report

##article.authors##

  • Ursula Cáceres Bernaola Hospital Central de la Fuerza Aérea del Perú
    • Claudia Becerra Núñez Hospital Central de la Fuerza Aerea del Peru https://orcid.org/0000-0002-6799-6100
      • Sabina Mendívil-Tuchía de Tai Hospital Central de la Fuerza Aérea del Perú
        • Jorge Ravelo-Hernández Hospital Central de la Fuerza Aérea del Perú

          DOI:

          https://doi.org/10.1590/SciELOPreprints.275

          Keywords:

          COVID-19, tocilizumab, interleukin 6 antagonists and inhibitors

          Abstract

          We present the case of an adult patient with COVID-19 pneumonia with rapid clinical-radiological progression, in whom the compassionate use of interleukin receptor blocker 6 (Tocilizumab) was used for the management of his disease.

          Downloads

          Download data is not yet available.

          Posted

          05/03/2020

          How to Cite

          COVID-19 Pneumonia and Tocilizumab use: Case Report. (2020). In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.275

          Section

          Health Sciences

          Copyright (c) 2020 Ursula Cáceres Bernaola, Claudia Becerra Núñez, Sabina Mendívil-Tuchía de Tai, Jorge Ravelo-Hernández

          Creative Commons License

          This work is licensed under a Creative Commons Attribution 4.0 International License.

          Crossref
          Scopus
          Google Scholar
          Europe PMC

          Plaudit